KR870001834A - 일본뇌염 바이러스의 정제방법 - Google Patents

일본뇌염 바이러스의 정제방법 Download PDF

Info

Publication number
KR870001834A
KR870001834A KR1019850005759A KR850005759A KR870001834A KR 870001834 A KR870001834 A KR 870001834A KR 1019850005759 A KR1019850005759 A KR 1019850005759A KR 850005759 A KR850005759 A KR 850005759A KR 870001834 A KR870001834 A KR 870001834A
Authority
KR
South Korea
Prior art keywords
encephalitis virus
japanese encephalitis
cellulose
purifying
solution containing
Prior art date
Application number
KR1019850005759A
Other languages
English (en)
Other versions
KR920009731B1 (ko
Inventor
구니아끼 사까모도
이사오 고도오
데츠오 가와하라
미츠오 사고오
Original Assignee
노나까 사네오
자이단 호오진 카가구오요비 겟세이리요호오 켄키유쇼.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노나까 사네오, 자이단 호오진 카가구오요비 겟세이리요호오 켄키유쇼. filed Critical 노나까 사네오
Publication of KR870001834A publication Critical patent/KR870001834A/ko
Application granted granted Critical
Publication of KR920009731B1 publication Critical patent/KR920009731B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

내용 없음.

Description

일본뇌염 바이러스의 정제방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 크로마트그라피용 겔로서 셀룰로스 또는 가교 다당류의 황산에스테르를 사용하는 컬럼 크로마토그래피에 일본뇌염 바이러스를 함유하는 용액을 거쳐서 되는 것을 특징으로 하는 일본뇌염 바이러스의 정제방법.
  2. 제1항에 있어서 일본뇌염 바이러스 함유 용액은 불활성 일본뇌염 바이러스를 함유하는 용액인 것을 특징으로 하는 일본뇌염 바이러스의 정제방법.
  3. 제1항에 있어서, 일본뇌염 바이러스함유, 액은 활성뇌염 바이러스를 함유하는 용액인 것을 특징으로 하는 일본뇌염 바이러스의 정제방법.
  4. 제1항 내지 3항중 어느 1항에 있어서, 가교 다당류의 황산에스테르는, 가교 황산 셀루로스, 가교황산 아가로스 및 가교황산 덱스트란으로 구성되는 군에서 선택되는 것을 특징으로 하는 일본뇌염 바이러스의 정제방법.
  5. 제1항 내지 3항중 어느 1항에 있어서, 셀롤로스의 황산 에스테르는, 결정성 셀룰로스 또는 결정영역과 비결경영역을 갖는 셀룰로스의 황산에스테르인 것을 특징으로 하는 일본뇌염 바이러스의 정제방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850005759A 1984-08-09 1985-08-09 일본뇌염 바이러스의 정제방법 KR920009731B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP167323 1984-08-09
JP59167323A JPS6147185A (ja) 1984-08-09 1984-08-09 日本脳炎ウイルスの精製方法
JP59-167323 1984-08-09

Publications (2)

Publication Number Publication Date
KR870001834A true KR870001834A (ko) 1987-03-28
KR920009731B1 KR920009731B1 (ko) 1992-10-22

Family

ID=15847614

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850005759A KR920009731B1 (ko) 1984-08-09 1985-08-09 일본뇌염 바이러스의 정제방법

Country Status (7)

Country Link
US (1) US4725546A (ko)
EP (1) EP0171765B1 (ko)
JP (1) JPS6147185A (ko)
KR (1) KR920009731B1 (ko)
AT (1) ATE54938T1 (ko)
CA (1) CA1251400A (ko)
DE (1) DE3578839D1 (ko)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1248075B (it) * 1991-06-18 1995-01-05 Sclavo Spa Processo per la purificazione del virus dell'epatite a (hav), virus cosi` purificato e composizioni vaccinali che lo contengono.
US5447859A (en) * 1993-07-16 1995-09-05 Viagene Method for the purification or removal of retroviruses using sulfated cellulose
ES2141929T3 (es) * 1994-03-22 2000-04-01 Immune Response Corp Inc Produccion y aislamiento muy eficientes de particulas viricas.
CN1063970C (zh) * 1994-12-06 2001-04-04 卫生部北京生物制品研究所 用鳞翅目粘虫卵巢细胞制备流行性乙脑疫苗的方法及疫苗
EP0841942B2 (fr) * 1995-08-01 2007-12-12 Sanofi Pasteur Procede de production industrielle d'un vaccin contre l'encephalite japonaise et vaccin obtenu
FR2737412B1 (fr) * 1995-08-01 1997-10-24 Pasteur Merieux Serums Vacc Procede de production d'un vaccin contre le virus de l'encephalite japonaise et vaccin obtenu par ce procede
US6207439B1 (en) * 1997-03-25 2001-03-27 Center For Disease Control Purification of Japanese encephalitis virus
EP1057889B1 (en) * 1998-10-05 2009-04-22 The Research Foundation for Microbial Diseases of Osaka University Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same
AU4472801A (en) * 2000-04-07 2001-10-23 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Inactivated japanese B encephalitis vaccine and process for producing the same
JP2002142770A (ja) 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
PL354822A1 (en) * 2002-06-30 2004-01-12 Instytut Immunologii i Terapii Doświadczalnej PANwe Wrocławiu Method of receiving purified bacteriophage preparations and new applications of polysaccharide or its esterificated derivative
AU2004249199B2 (en) * 2003-06-18 2008-07-24 Onyx Pharmaceuticals, Inc. Method for purifying virus
US20070269414A1 (en) 2003-11-04 2007-11-22 Shinji Okano Method for Producing Gene Transferred Denritic Cells
WO2006122964A1 (en) * 2005-05-19 2006-11-23 Crucell Holland B.V. Methods for the production of a whole-inactivated west nile virus vaccine
EP1724338A1 (en) * 2005-05-19 2006-11-22 Crucell Holland B.V. Methods for the production of a whole-inactivated West Nile Virus vaccine
EP1916298B1 (en) 2005-06-14 2011-12-28 Dnavec Corporation Methods for producing monoclonal antibodies
CA2636600A1 (en) 2006-01-17 2007-07-26 Dnavec Corporation Novel protein expression system
WO2008007581A1 (fr) 2006-07-13 2008-01-17 Dnavec Corporation Vecteur de virus paramyxoviridae non répliquant
US20100203027A1 (en) 2007-04-27 2010-08-12 Kyushu Univeristy National University Viral vector for gene therapy
JP5716297B2 (ja) 2009-06-25 2015-05-13 Jnc株式会社 クロマトグラフィー用充填剤、その製造方法、およびそれを用いたウイルス用ワクチンの製造方法
CN102985536B (zh) 2010-04-14 2017-12-05 Emd密理博公司 生产高效价、高纯度的病毒母液的方法及使用其的方法
DE102013017014B4 (de) 2013-10-14 2017-03-30 Sartorius Stedim Biotech Gmbh Sulfatierte Cellulosehydrat-Membran, Verfahren zur ihrer Herstellung und Verwendung der Membran als Adsorptionsmembran für die Virenaufreinigung

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL131092C (ko) *
US3105012A (en) * 1961-10-19 1963-09-24 Parke Davis & Co Antigen products and means for producing the same
SE356735B (ko) * 1970-12-02 1973-06-04 Svenska Cellulosa Ab
JPS565204B2 (ko) * 1972-06-16 1981-02-04
US3842062A (en) * 1972-09-27 1974-10-15 Du Pont Water-soluble complexes of protein and anionic polyelectrolytes such as sodium carboxymethyl cellulose
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4160019A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Detection of cancer associated polypeptide antigen and preparation of antibodies thereto
IL49752A (en) * 1975-07-09 1979-07-25 Kabi Ab Compositions having affinity for hepatitis virus and method for hepatitis virus removal or concentration
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
JPS53133627A (en) * 1977-04-25 1978-11-21 Nippon Seibutsu Kagaku Kenkiyu High purity deactivated vaccine for japanese encephalitis
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
JPS5879929A (ja) * 1981-11-05 1983-05-13 Biseibutsu Kagaku Kenkyusho:Kk 日本脳炎・豚パルポ混合ワクチン
US4434093A (en) * 1982-07-26 1984-02-28 Ortho Diagnostic Systems Inc. Methods for preparation of HBs Ag free gamma globulins
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen

Also Published As

Publication number Publication date
EP0171765A2 (en) 1986-02-19
JPS6147185A (ja) 1986-03-07
KR920009731B1 (ko) 1992-10-22
JPS6233879B2 (ko) 1987-07-23
DE3578839D1 (de) 1990-08-30
EP0171765A3 (en) 1988-01-13
EP0171765B1 (en) 1990-07-25
CA1251400A (en) 1989-03-21
ATE54938T1 (de) 1990-08-15
US4725546A (en) 1988-02-16

Similar Documents

Publication Publication Date Title
KR870001835A (ko) 인플루엔자 바이러스의 정제방법
KR870001834A (ko) 일본뇌염 바이러스의 정제방법
KR870001836A (ko) 광견병 바이러스의 정제방법
DE69834584D1 (de) Verfahren zur selektiven Derivatisierung von Taxanen
ES2080119T3 (es) Composicion suavizante de tejidos.
ATE66229T1 (de) Verfahren zur herstellung von (6r)-tetrahydro-l- biopterin.
BR8304990A (pt) Meio aquoso de polimerizacao;processo para produzir polibutadieno
SE7704338L (sv) Forfaringssett for framstellning av porosa cellulosaperlor
BE854916A (fr) Procede de purification possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application
IT1099144B (it) Processo per la separazione di contaminanti polimerici da soluzioni acquose assorbenti usate per trattare correnti gassose contenenti gas organici
BR7901454A (pt) Processo para produzir uma chapa de aco de silicio de granulacao orientada
MA18789A1 (fr) Distillateur solaire de purification par evaporation
BR8304261A (pt) Sistema catalitico para polimerizacao de olefinas,componente do mesmo e processo para produzir componente
DE69411492D1 (de) Verfahren zur Reinigung von mittleren Olefinen
BR8501208A (pt) Processo para melhorar os rendimentos dos produtos resultantes de coqueificacao retardada
JPS5231021A (en) Process for purification of crude n-omega-long-chain acyl basic amino acid or its metal salt
KR910015699A (ko) 리포코틴의 정제방법
BR8705619A (pt) Processo para inibir microorganismos
KR870002774A (ko) α-L-아스파틸-L-페닐알라닌 메틸 에스테르의 정제방법
JPS5382717A (en) Purification of sebacic acid or its ester
KR890015993A (ko) 피루베이트 제조 방법
KR930006151A (ko) 지렁이로부터 프로테아제를 분리 정제하는 방법
IT1041828B (it) Processo per la depurazione biologica di acque di scarico
KR880008814A (ko) 겔여과 컬럼에 의한 엔도톡신의 제거방법
KR960031593A (ko) 타타르산을 이용한 수두 바이러스의 활성 증진 방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040629

Year of fee payment: 13

EXPY Expiration of term